These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 15934871

  • 1. Emerging chemotherapeutic strategies for Huntington's disease.
    Ryu H, Ferrante RJ.
    Expert Opin Emerg Drugs; 2005 May; 10(2):345-63. PubMed ID: 15934871
    [Abstract] [Full Text] [Related]

  • 2. Huntington's disease: progress and potential in the field.
    Stack EC, Ferrante RJ.
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1933-53. PubMed ID: 18042002
    [Abstract] [Full Text] [Related]

  • 3. Huntington's disease: which drugs might help patients?
    Hannan AJ.
    IDrugs; 2004 Apr; 7(4):351-8. PubMed ID: 15057641
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.
    Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ.
    Biochim Biophys Acta; 2006 Mar; 1762(3):373-80. PubMed ID: 16364609
    [Abstract] [Full Text] [Related]

  • 5. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.
    Naia L, Ribeiro MJ, Rego AC.
    Rev Neurosci; 2011 Dec 02; 23(1):13-28. PubMed ID: 22150069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The therapeutic role of creatine in Huntington's disease.
    Ryu H, Rosas HD, Hersch SM, Ferrante RJ.
    Pharmacol Ther; 2005 Nov 02; 108(2):193-207. PubMed ID: 16055197
    [Abstract] [Full Text] [Related]

  • 8. Selective neuronal degeneration in Huntington's disease.
    Cowan CM, Raymond LA.
    Curr Top Dev Biol; 2006 Nov 02; 75():25-71. PubMed ID: 16984809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug discovery and development for Huntington's disease - an orphan indication with high medical need.
    Heitz F, La Rosa S, Gonzalez-Couto E, Gaviraghi G, Terstappen GC.
    IDrugs; 2008 Sep 02; 11(9):653-60. PubMed ID: 18763216
    [Abstract] [Full Text] [Related]

  • 12. The molecular biology of Huntington's disease.
    Ho LW, Carmichael J, Swartz J, Wyttenbach A, Rankin J, Rubinsztein DC.
    Psychol Med; 2001 Jan 02; 31(1):3-14. PubMed ID: 11200958
    [Abstract] [Full Text] [Related]

  • 13. Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.
    Stack EC, Matson WR, Ferrante RJ.
    Ann N Y Acad Sci; 2008 Dec 02; 1147():79-92. PubMed ID: 19076433
    [Abstract] [Full Text] [Related]

  • 14. Investigational agents for the management of Huntington's disease.
    Müller T.
    Expert Opin Investig Drugs; 2017 Feb 02; 26(2):175-185. PubMed ID: 27927041
    [Abstract] [Full Text] [Related]

  • 15. Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
    Ferrante RJ.
    Biochim Biophys Acta; 2009 Jun 02; 1792(6):506-20. PubMed ID: 19362590
    [Abstract] [Full Text] [Related]

  • 16. The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?
    Gil-Mohapel J, Brocardo PS, Christie BR.
    Curr Drug Targets; 2014 Apr 02; 15(4):454-68. PubMed ID: 24428525
    [Abstract] [Full Text] [Related]

  • 17. [Huntington's disease: clinical and molecular genetics].
    Warita H, Shiro Y, Kashihara K, Abe K.
    Nihon Rinsho; 1999 Apr 02; 57(4):896-9. PubMed ID: 10222786
    [Abstract] [Full Text] [Related]

  • 18. The role of iron imaging in Huntington's disease.
    van den Bogaard SJ, Dumas EM, Roos RA.
    Int Rev Neurobiol; 2013 Apr 02; 110():241-50. PubMed ID: 24209441
    [Abstract] [Full Text] [Related]

  • 19. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease.
    van Dellen A, Grote HE, Hannan AJ.
    Clin Exp Pharmacol Physiol; 2005 Dec 02; 32(12):1007-19. PubMed ID: 16445565
    [Abstract] [Full Text] [Related]

  • 20. Emerging drug therapies in Huntington's disease.
    Mason SL, Barker RA.
    Expert Opin Emerg Drugs; 2009 Jun 02; 14(2):273-97. PubMed ID: 19453283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.